From the Big Apple to Ohio Coal Country, 340B Helps Low-Income Cancer Patients July 19, 2017 – The Center for Medicare and Medicaid Services’ proposal to slash 340B hospitals’ reimbursement for Medicare Part B drugs would punch a big hole in America’s healthcare safety net. Low-income...
Statement by Erin Bliss, Assistant Inspector General for Evaluation and Inspections Office of Inspector General U.S. Department of Health and Human Services, again cited the HRSA report: “In 1992, Congress established the 340B program to generate savings for certain safety-net health care providers by allowing...
Statement of Debra A. Draper, Director, Health Care, of the Government Accounting Office (GAO), citing the Health Resources and Services Administration (HRSA) that administers the 340B program, stated, in part, “the purpose of the program is to enable covered entities to stretch scarce federal resources...
340B Matters, a coalition of stakeholders interested in preserving the intent and the integrity of the 340B program, released the following statement in the wake of the today’s House congressional oversight hearing on the 340B program: 340B Matters strongly supports responsible oversight and full transparency of...
When Debbie Scott from Alabama was diagnosed with colon cancer, she had no insurance and wasn’t sure how she would pay for treatment. Fortunately, she turned to Monroe County Hospital, which participates in the 340B drug discount program. For 25 years, 340B has been helping...
The contract pharmacy program is critical for 340B hospitals to maintain and expand access to care for low-income and rural patients. Without their contract pharmacy benefit, hospitals would face difficulties maintaining the same level of care for patients in need, particularly Medicaid patients, rural populations,...
The contract pharmacy program is critical for 340B hospitals to maintain and expand access to care for low-income and rural patients. Without their contract pharmacy benefit, hospitals would face difficulties maintaining the same level of care for patients in need, particularly Medicaid patients, rural populations,...
Hospital lobbying groups say they're hearing President Donald Trump may be backing off plans to scale back a federal program that requires drugmakers to give discounted products to hospitals that treat a high number of poor patients. Read More: http://www.modernhealthcare.com/article/20170712/NEWS/170719964...
“If it ain’t broke, don’t fix it” might be a cliché, but when it comes to healthcare policy, it’s sage wisdom. It certainly applies to a small but critically important drug discount program with a quarter century of success at supporting safety-net health providers and...
In 1992, the government established a federal drug discount program that required the pharmaceutical industry to provide discounted drugs for public and non-profit hospitals and clinics that serve high numbers of the poor. It's called 340B and MetroHealth relies on it to give lifesaving medicine...
